Skip to main content
PharmGen Science, Inc. logo

PharmGen Science, Inc. — Investor Relations & Filings

Ticker · 004720 ISIN · KR7004720009 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2020-11-16 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 004720

About PharmGen Science, Inc.

http://www.pharmgenscience.com/en/

PharmGen Science, Inc. is a pharmaceutical company engaged in the research, development, production, and sale of medicaments. The company's portfolio encompasses a range of prescription (ETC) and over-the-counter (OTC) drugs, including analgesics, antibiotics, and anti-inflammatory agents. A key strategic focus for the company is the discovery and development of novel drugs for gastrointestinal (GI) disorders. PharmGen Science aims to provide integrated pharmaceutical solutions by leveraging its diverse infrastructure and global network.

Recent filings

Filing Released Lang Actions
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Wooridul Pharmaceutical Co., Ltd. for the period ending September 30, 2020. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-16 Korean
[기재정정]주요사항보고서(신주인수권부사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '정정신고(보고)' (Correction Report) regarding the issuance of bonds with warrants (신주인수권부사채 발행결정). It details specific amendments to the terms of the bond, including put and call options, and follows the standard format for a major report (주요사항보고서) submitted to the Financial Supervisory Service/Korea Exchange. Since it is a detailed disclosure of a capital-raising event and its subsequent correction, it falls under the 'Share Issue/Capital Change' category.
2020-11-13 Korean
주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the issuance of bonds with warrants (신주인수권부사채 발행결정). This document details the terms of the financing, including interest rates, maturity, put options, and the use of proceeds. It is a formal regulatory filing concerning capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2020-11-11 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for '우리들제약 주식회사' covering the period from 2020-01-01 to 2020-06-30. It contains detailed financial statements, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider (director or major shareholder) changes their shareholding position. This falls under the category of 'Director's Dealing' (DIRS), which covers insider trades and changes in ownership by company executives.
2020-08-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (disposal of shares) by an executive (Yeo Deok-ju) of Wooridul Pharmaceutical. This type of filing is specifically categorized as a Director's Dealing (DIRS) report, as it documents insider trading activity by company management.
2020-08-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.